Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 75.91
(-6.86%)
INR 75.91
(-6.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -48.09 Million INR | -1455.17% |
| 2022 | 3.54 Million INR | 117.86% |
| 2021 | -19.86 Million INR | -16.1% |
| 2020 | -17.11 Million INR | -1404.1% |
| 2019 | -1.13 Million INR | 5.35% |
| 2018 | -1.2 Million INR | 78.09% |
| 2017 | -5.48 Million INR | -32.08% |
| 2016 | -4.15 Million INR | 60.94% |
| 2015 | -10.63 Million INR | -1.46% |
| 2014 | -10.48 Million INR | 21.91% |
| 2013 | -13.42 Million INR | -33.39% |
| 2012 | -10.06 Million INR | 0.0% |
| 2009 | -11.98 Million INR | 8.04% |
| 2008 | -13.03 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | -48.09 Million INR | -1455.17% |
| 2023 Q2 | 1.24 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | -48.09 Million INR | 0.0% |
| 2022 Q4 | 3.54 Million INR | 0.0% |
| 2022 Q2 | 1.93 Million INR | 0.0% |
| 2022 FY | 3.54 Million INR | 117.86% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | 100.0% |
| 2021 Q3 | - INR | 100.0% |
| 2021 FY | -19.86 Million INR | -16.1% |
| 2021 Q1 | - INR | 100.0% |
| 2021 Q2 | -18.66 Million INR | 0.0% |
| 2021 Q4 | -19.86 Million INR | 0.0% |
| 2020 Q2 | -1.99 Million INR | 0.0% |
| 2020 FY | -17.11 Million INR | -1404.1% |
| 2020 Q4 | -17.11 Million INR | 0.0% |
| 2019 Q2 | 1.59 Million INR | 0.0% |
| 2019 FY | -1.13 Million INR | 5.35% |
| 2019 Q4 | -1.13 Million INR | 0.0% |
| 2018 Q4 | -1.2 Million INR | 0.0% |
| 2018 FY | -1.2 Million INR | 78.09% |
| 2018 Q2 | 1.98 Million INR | 0.0% |
| 2017 Q2 | -2.42 Million INR | 0.0% |
| 2017 FY | -5.48 Million INR | -32.08% |
| 2017 Q4 | -5.48 Million INR | 0.0% |
| 2016 Q4 | -4.15 Million INR | 0.0% |
| 2016 Q2 | -9.18 Million INR | 0.0% |
| 2016 FY | -4.15 Million INR | 60.94% |
| 2015 Q4 | -10.63 Million INR | 0.0% |
| 2015 FY | -10.63 Million INR | -1.46% |
| 2014 FY | -10.48 Million INR | 21.91% |
| 2014 Q4 | -10.48 Million INR | 0.0% |
| 2013 Q4 | -13.42 Million INR | 0.0% |
| 2013 FY | -13.42 Million INR | -33.39% |
| 2012 Q4 | -10.06 Million INR | 0.0% |
| 2012 FY | -10.06 Million INR | 0.0% |
| 2009 FY | -11.98 Million INR | 8.04% |
| 2009 Q4 | -11.98 Million INR | 0.0% |
| 2008 FY | -13.03 Million INR | 0.0% |
| 2008 Q4 | -13.03 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | 290.764% |
| Sastasundar Ventures Limited | -297.24 Million INR | 83.819% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 111.141% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | -7.785% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 36.84% |
| Sunil Healthcare Limited | 625.4 Million INR | 107.691% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -693.958% |
| MedPlus Health Services Limited | 8.67 Billion INR | 100.554% |
| Zenith Healthcare Limited | -25.45 Million INR | -88.938% |
| Patidar Buildcon Limited | 25.12 Million INR | 291.427% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 44.04% |
| Roopa Industries Limited | 216.01 Million INR | 122.266% |
| Smruthi Organics Limited | 111.28 Million INR | 143.219% |
| Trident Lifeline Limited | 117.56 Million INR | 140.914% |
| Bacil Pharma Limited | 569 Thousand INR | 8553.076% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 228.991% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 227.365% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 106.977% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | -320.805% |
| PANJON LTD. | -12.8 Million INR | -275.531% |
| Tyche Industries Limited | -788.94 Million INR | 93.903% |
| Trimurthi Limited | -1.17 Million INR | -3982.329% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 457.739% |
| Anuh Pharma Limited | -69.8 Million INR | 31.099% |
| Crestchem Limited | -1.45 Million INR | -3217.103% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 20.803% |
| Zenlabs Ethica Limited | 139.54 Million INR | 134.467% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 224.526% |
| ANG Lifesciences India Limited | 671.01 Million INR | 107.168% |
| Parmax Pharma Limited | 51.8 Million INR | 192.836% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 104.607% |
| Deccan Health Care Limited | -7.07 Million INR | -579.734% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 29.542% |
| Norris Medicines Limited | 214.86 Million INR | 122.386% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 104.594% |
| Veerhealth Care Limited | -2.38 Million INR | -1916.688% |
| Makers Laboratories Limited | 172.59 Million INR | 127.868% |
| Lactose (India) Limited | 373.97 Million INR | 112.861% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 108.419% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 136.41% |
| Mercury Laboratories Limited | -26.72 Million INR | -79.947% |
| Gennex Laboratories Limited | -552.54 Million INR | 91.295% |
| PRAVEG LIMITED | -434.98 Million INR | 88.943% |
| Denis Chem Lab Limited | -236.28 Million INR | 79.644% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 105.218% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 93.926% |
| Colinz Laboratories Limited | -64.3 Million INR | 25.201% |
| Godavari Drugs Limited | 530.02 Million INR | 109.075% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -416.627% |
| Zenotech Laboratories Limited | -196.85 Million INR | 75.567% |
| Panchsheel Organics Limited | -157.82 Million INR | 69.524% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 123.828% |
| Vivanza Biosciences Limited | 50.02 Million INR | 196.146% |
| Phaarmasia Limited | -4.89 Million INR | -882.193% |
| Bharat Parenterals Limited | 1.48 Billion INR | 103.231% |
| Medi-Caps Limited | -3.21 Million INR | -1396.515% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 48.358% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 10.738% |
| BDH Industries Limited | -164.47 Million INR | 70.756% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 161.113% |
| Coral Laboratories Limited | -612.82 Million INR | 92.151% |
| Concord Drugs Limited | 164.48 Million INR | 129.241% |
| Beryl Drugs Limited | 48.7 Million INR | 198.748% |
| Evoq Remedies Limited | 41.14 Million INR | 216.89% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 141.375% |
| Transchem Limited | -3.16 Million INR | -1420.645% |
| Parnax Lab Limited | 787.61 Million INR | 106.107% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 17.902% |
| Kerala Ayurveda Limited | 447.82 Million INR | 110.74% |
| Cian Healthcare Limited | 544.97 Million INR | 108.826% |
| Trinity League India Limited | -12 Thousand INR | -400716.667% |
| Syschem (India) Limited | 3.53 Million INR | 1461.778% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 103.448% |
| Natural Capsules Limited | 956.68 Million INR | 105.028% |
| Auro Laboratories Limited | 252.51 Million INR | 119.048% |